Clinical Trial Update: A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing mycophenolic acid exposure (AUC) in renal transplant recipients before and after switching from mycophenolate mofetil …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)
• Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: Irmandade Santa Casa de Misericórdia de Porto Alegre | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED